Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further...
Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.
With the Fluidlab R-300, the start-up Anvajo offers a portable device that bundles the two central laboratory technologies spectrometry and automated cell counting. It...
25.04.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...
16.01.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a non-exclusive license agreement with Amgen for...
08.01.2013
- Sartorius Stedim Biotech, a pharmaceutical and biotech supplier, today announced a substantial expansion of its product rray in the cell culture range. The company signed a...
